Murase, J. E. .; Munera-Campos, M. .; Hong, H. C.- ho .; Taieb, A. .; Chung, W.-H. .; Reck Atwater, A.; Rueda, M. J. .; Zhong, J. .; Buziqui Piruzeli, M. L. .; Pau-Charles, I. .; Deleuran, M. . Lebrikizumab-Treated Patients With Atopic Dermatitis Had No Increase in Treatment-Emergent Adverse Events of Facial, Head, and Neck Erythema Compared to Placebo. J of Skin 2023, 7, s272.